SB225002 inhibits prostate cancer invasion and attenuates the expression of BSP, OPN and MMP‑2.

Oncol Rep · 2018 · PMC6072299 · PMID 29917166

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

By contrast, following treatment with SB225002 treatment, the αvβ3 expression levels showed an increasing trend in the three cell lines.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.